Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations
Lindsey Oudijk(Erasmus MC), Ronald R. de Krijger(University Medical Center Utrecht), Felix Beuschlein(University of Zurich), Aguirre A. de Cubas(Medical University of South Carolina), Marcel Smid(Erasmus MC), Esther Korpershoek(Radboud University Nijmegen), Massimo Mannelli(University of Florence), Christiane Neuhofer, Hans Stoop(Inserm), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Thomas Papathomas(NIHR Birmingham Biomedical Research Centre), David F. Restuccia(Children's Cancer Institute Australia), J.W. Oosterhuis, Winand N.M. Dinjens(Erasmus MC), U Lichtenauer(Inserm), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5)
Cited by 24
Related Papers
PI3K-PKB/Akt Pathway
|Cold Spring Harbor Perspectives in Biology|2012|1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791